Clinical Trials in Tangshan, China
Locations / Tangshan, China
Delta Trials hosts 168 clinical trials conducted in Tangshan, China, making it a notable site of clinical research activity. These trials covering 205 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 5 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Tangshan.
168
Total Trials
205
Conditions
5
Terminated since 2020
Browse by condition (205 total)
- Acute ischemic stroke 9 trialsAll Acute ischemic stroke trials
- Breast cancer 7 trialsAll Breast cancer trials
- Diabetes mellitus, type 2 4 trialsAll Diabetes mellitus, type 2 trials
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- Coronary artery disease 4 trialsAll Coronary artery disease trials
- Ischemic stroke 4 trialsAll Ischemic stroke trials
- Stroke 3 trialsAll Stroke trials
- Hemophilia b 3 trialsAll Hemophilia b trials
- Non-small cell lung cancer 3 trialsAll Non-small cell lung cancer trials
- Soft tissue injuries 3 trialsAll Soft tissue injuries trials
- Hypertension 3 trialsAll Hypertension trials
- Acute coronary syndrome 3 trialsAll Acute coronary syndrome trials
- Acute ischaemic stroke 3 trialsAll Acute ischaemic stroke trials
- Type 2 diabetes 3 trialsAll Type 2 diabetes trials
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Her2-positive breast cancer 2 trialsAll Her2-positive breast cancer trials
- Thrombosis 2 trialsAll Thrombosis trials
- Thromboembolism 2 trialsAll Thromboembolism trials
- Coronary disease 2 trialsAll Coronary disease trials
- All Primary immune thrombocytopenia (itp) trials